214 related articles for article (PubMed ID: 16555582)
21. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.
Nishiyama A; Yao L; Nagai Y; Miyata K; Yoshizumi M; Kagami S; Kondo S; Kiyomoto H; Shokoji T; Kimura S; Kohno M; Abe Y
Hypertension; 2004 Apr; 43(4):841-8. PubMed ID: 14769808
[TBL] [Abstract][Full Text] [Related]
22. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats.
Tanabe A; Naruse M; Hara Y; Sato A; Tsuchiya K; Nishikawa T; Imaki T; Takano K
J Hypertens; 2004 May; 22(5):1017-23. PubMed ID: 15097243
[TBL] [Abstract][Full Text] [Related]
23. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade.
Oeckler RA; Kaminski PM; Wolin MS
Circ Res; 2003 Jan; 92(1):23-31. PubMed ID: 12522117
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective effects of pitavastatin on cardiac performance and remodeling in failing rat hearts.
Kobayashi N; Takeshima H; Fukushima H; Koguchi W; Mamada Y; Hirata H; Machida Y; Shinoda M; Suzuki N; Yokotsuka F; Tabei K; Matsuoka H
Am J Hypertens; 2009 Feb; 22(2):176-82. PubMed ID: 19039310
[TBL] [Abstract][Full Text] [Related]
25. Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.
Sun GP; Kohno M; Guo P; Nagai Y; Miyata K; Fan YY; Kimura S; Kiyomoto H; Ohmori K; Li DT; Abe Y; Nishiyama A
J Am Soc Nephrol; 2006 Aug; 17(8):2193-201. PubMed ID: 16790507
[TBL] [Abstract][Full Text] [Related]
26. Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Zeng ZH; Luo BH; Gao YJ; Su CJ; He CC; Yi JJ; Li N; Lee RM
Eur J Pharmacol; 2004 Oct; 503(1-3):129-33. PubMed ID: 15496307
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells.
Sugiyama T; Yoshimoto T; Tsuchiya K; Gochou N; Hirono Y; Tateno T; Fukai N; Shichiri M; Hirata Y
Endocrinology; 2005 Sep; 146(9):3900-6. PubMed ID: 15932931
[TBL] [Abstract][Full Text] [Related]
28. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
[TBL] [Abstract][Full Text] [Related]
30. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure.
Tojo A; Onozato ML; Kobayashi N; Goto A; Matsuoka H; Fujita T
Hypertension; 2002 Dec; 40(6):834-9. PubMed ID: 12468566
[TBL] [Abstract][Full Text] [Related]
32. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients.
Keidar S; Gamliel-Lazarovich A; Kaplan M; Pavlotzky E; Hamoud S; Hayek T; Karry R; Abassi Z
Circ Res; 2005 Oct; 97(9):946-53. PubMed ID: 16179584
[TBL] [Abstract][Full Text] [Related]
33. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
Pu Q; Neves MF; Virdis A; Touyz RM; Schiffrin EL
Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645
[TBL] [Abstract][Full Text] [Related]
34. Aldosterone induction of hepatic stellate cell contraction through activation of RhoA/ROCK-2 signaling pathway.
Ji H; Meng Y; Zhang X; Luo W; Wu P; Xiao B; Zhang Z; Li X
Regul Pept; 2011 Aug; 169(1-3):13-20. PubMed ID: 21545816
[TBL] [Abstract][Full Text] [Related]
35. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
[TBL] [Abstract][Full Text] [Related]
36. Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats.
Wang JM; Wang Y; Zhu ZS; Zhang MC; Zou Y; Li JJ; Li MJ; Jiang XJ; Li XY
Life Sci; 2004 Jun; 75(4):407-20. PubMed ID: 15147828
[TBL] [Abstract][Full Text] [Related]
37. Aldosterone-induced inflammation in the rat heart : role of oxidative stress.
Sun Y; Zhang J; Lu L; Chen SS; Quinn MT; Weber KT
Am J Pathol; 2002 Nov; 161(5):1773-81. PubMed ID: 12414524
[TBL] [Abstract][Full Text] [Related]
38. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA.
Kobayashi N; Hara K; Watanabe S; Higashi T; Matsuoka H
Am J Hypertens; 2000 Feb; 13(2):199-207. PubMed ID: 10701821
[TBL] [Abstract][Full Text] [Related]
39. Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling.
Lijnen PJ; Petrov VV
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):541-64. PubMed ID: 14571285
[TBL] [Abstract][Full Text] [Related]
40. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
